Advertisement

Topics

Setback for J&J as FDA panel turns down arthritis drug sirukumab

07:10 EDT 3 Aug 2017 | PMLIVE

US regulator concerned with the drug’s safety

Original Article: Setback for J&J as FDA panel turns down arthritis drug sirukumab

NEXT ARTICLE

More From BioPortfolio on "Setback for J&J as FDA panel turns down arthritis drug sirukumab"

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...